Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

DGAP-News: ​​​​​​​PAION AG PUBLISHES GROUP QUARTERLY STATEMENT FOR THE FIRST QUARTER OF 2022: https://upload.wikimedia.org/wikipedia/de/thumb/4/45/Paion-logo.svg/640px-Paion-logo.svg.png
DGAP-News: ​​​​​​​PAION AG PUBLISHES GROUP QUARTERLY STATEMENT FOR THE FIRST QUARTER OF 2022
DGAP-News: ​​​​​​​PAION AG PUBLISHES GROUP QUARTERLY STATEMENT FOR THE FIRST QUARTER OF 2022
eqs_en 
0 18.05.22
DGAP-News: Evotec and Sernova announce exclusive strategic partnership for iPSC-based beta cell replacement therapy to advance a 'functional cure' for diabetes: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: Evotec and Sernova announce exclusive strategic partnership for iPSC-based beta cell replacement therapy to advance a 'functional cure' for diabetes
DGAP-News: Evotec and Sernova announce exclusive strategic partnership for iPSC-based beta cell replacement therapy to advance a 'functional cure' for diabetes
eqs_en 
0 17.05.22
DGAP-News: Gerresheimer AG: Gerresheimer executes on its growth strategy in Emerging Markets boosting capacities in India: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
DGAP-News: Gerresheimer AG: Gerresheimer executes on its growth strategy in Emerging Markets boosting capacities in India
DGAP-News: Gerresheimer AG: Gerresheimer executes on its growth strategy in Emerging Markets boosting capacities in India
eqs_en 
0 16.05.22
DGAP-News: Carl Zeiss Meditec achieves further significant growth in revenue and order intake in first half 2021/22http://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
DGAP-News: Carl Zeiss Meditec achieves further significant growth in revenue and order intake in first half 2021/22
DGAP-News: Carl Zeiss Meditec achieves further significant growth in revenue and order intake in first half 2021/22
eqs_en 
0 13.05.22
DGAP-News: MorphoSys to Present New Data on Pelabresib and Monjuvi® (tafasitamab-cxix) at the 2022 European Hematology Association (EHA) and American Society of Clinical Oncology (ASCO) Annual Meetings: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-News: MorphoSys to Present New Data on Pelabresib and Monjuvi® (tafasitamab-cxix) at the 2022 European Hematology Association (EHA) and American Society of Clinical Oncology (ASCO) Annual Meetings
DGAP-News: MorphoSys to Present New Data on Pelabresib and Monjuvi® (tafasitamab-cxix) at the 2022 European Hematology Association (EHA) and American Society of Clinical Oncology (ASCO) Annual Meetings
eqs_en 
0 12.05.22
DGAP-News: RHÖN-KLINIKUM Aktiengesellschaft: Financial year 2022 again marked by COVID-19 pandemic: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23735/Rhoen-klinikum.svg.png
DGAP-News: RHÖN-KLINIKUM Aktiengesellschaft: Financial year 2022 again marked by COVID-19 pandemic
DGAP-News: RHÖN-KLINIKUM Aktiengesellschaft: Financial year 2022 again marked by COVID-19 pandemic
eqs_en 
0 12.05.22
DGAP-News: Evotec SE reports results for the first quarter 2022 and provides corporate update: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: Evotec SE reports results for the first quarter 2022 and provides corporate update
DGAP-News: Evotec SE reports results for the first quarter 2022 and provides corporate update
eqs_en 
0 11.05.22
DGAP-News: Evotec and Bristol Myers Squibb extend and expand strategic partnership in protein degradation: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: Evotec and Bristol Myers Squibb extend and expand strategic partnership in protein degradation
DGAP-News: Evotec and Bristol Myers Squibb extend and expand strategic partnership in protein degradation
eqs_en 
0 10.05.22
Gerresheimer AG: Gerresheimer and Portal enter strategic partnership to treat chronically ill patients with innovative needle-free drug-delivery solution: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
Gerresheimer AG: Gerresheimer and Portal enter strategic partnership to treat chronically ill patients with innovative needle-free drug-delivery solution
Gerresheimer AG: Gerresheimer and Portal enter strategic partnership to treat chronically ill patients with innovative needle-free drug-delivery solution
eqs_en 
0 09.05.22
DGAP-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft: The Board of Management of RHÖN-KLINIKUM AG considers timely agreement with the State of Hesse on granting subsidies to UKGM to be questionable: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23735/Rhoen-klinikum.svg.png
DGAP-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft: The Board of Management of RHÖN-KLINIKUM AG considers timely agreement with the State of Hesse on granting subsidies to UKGM to be questionable
DGAP-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft: The Board of Management of RHÖN-KLINIKUM AG considers timely agreement with the State of Hesse on granting subsidies to UKGM to be questionable
eqs_en 
0 09.05.22
DGAP-News: Biotest AG: Dr Bernhard Ehmer new Chairman of the Supervisory Board of Biotest AG: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24092/375px-Biotest_logo.svg.png
DGAP-News: Biotest AG: Dr Bernhard Ehmer new Chairman of the Supervisory Board of Biotest AG
DGAP-News: Biotest AG: Dr Bernhard Ehmer new Chairman of the Supervisory Board of Biotest AG
eqs_en 
0 06.05.22
AEVIS VICTORIA SA: New revolving credit facility of CHF 250 million for Swiss Medical Network SAhttp://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png
AEVIS VICTORIA SA: New revolving credit facility of CHF 250 million for Swiss Medical Network SA
AEVIS VICTORIA SA: New revolving credit facility of CHF 250 million for Swiss Medical Network SA
eqs_en 
0 06.05.22
Waters and University of Delaware Announce Official Opening of Immerse Delaware Lab
Waters and University of Delaware Announce Official Opening of Immerse Delaware Lab


Waters Corporation (NYSE: WAT) and The University of Delaware announced the grand opening of Immerse™ Delaware, a new Waters innovation and research laboratory. As part of their multi-year research

BusinessWire_EN 
0 05.05.22
DGAP-News: Biotest AG: Annual General Meeting approves dividend distribution: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24092/375px-Biotest_logo.svg.png
DGAP-News: Biotest AG: Annual General Meeting approves dividend distribution
DGAP-News: Biotest AG: Annual General Meeting approves dividend distribution
eqs_en 
0 05.05.22
DGAP-News: Biotest AG: Biotest records sales of € 115 million in the first quarter of 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24092/375px-Biotest_logo.svg.png
DGAP-News: Biotest AG: Biotest records sales of € 115 million in the first quarter of 2022
DGAP-News: Biotest AG: Biotest records sales of € 115 million in the first quarter of 2022
eqs_en 
0 05.05.22
DGAP-News: STRATEC POSTS GOOD START TO YEAR AND FURTHER SALES GROWTH IN FIRST QUARTER OF 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24071/375px-Stratec-Biomedical-Logo.svg.png
DGAP-News: STRATEC POSTS GOOD START TO YEAR AND FURTHER SALES GROWTH IN FIRST QUARTER OF 2022
DGAP-News: STRATEC POSTS GOOD START TO YEAR AND FURTHER SALES GROWTH IN FIRST QUARTER OF 2022
eqs_en 
0 05.05.22
DGAP-News: MorphoSys AG Reports First Quarter 2022 Financial Results: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-News: MorphoSys AG Reports First Quarter 2022 Financial Results
DGAP-News: MorphoSys AG Reports First Quarter 2022 Financial Results
eqs_en 
0 04.05.22
DGAP-News: Evotec SE to announce results for the first quarter 2022 on 11 May 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: Evotec SE to announce results for the first quarter 2022 on 11 May 2022
DGAP-News: Evotec SE to announce results for the first quarter 2022 on 11 May 2022
eqs_en 
0 04.05.22
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care reports first quarter results in line with its expectations despite significant headwinds: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23608/Fresenius_Medical_Care_20xx_logo.svg.png
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care reports first quarter results in line with its expectations despite significant headwinds
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care reports first quarter results in line with its expectations despite significant headwinds
eqs_en 
0 04.05.22
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet to succeed Rice Powell as Chief Executive Officer of Fresenius Medical Care: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23608/Fresenius_Medical_Care_20xx_logo.svg.png
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet to succeed Rice Powell as Chief Executive Officer of Fresenius Medical Care
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet to succeed Rice Powell as Chief Executive Officer of Fresenius Medical Care
eqs_en 
0 03.05.22
DGAP-Adhoc: Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet succeeds Rice Powell as CEO of the Management Board of Fresenius Medical Care: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23608/Fresenius_Medical_Care_20xx_logo.svg.png
DGAP-Adhoc: Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet succeeds Rice Powell as CEO of the Management Board of Fresenius Medical Care
DGAP-Adhoc: Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet succeeds Rice Powell as CEO of the Management Board of Fresenius Medical Care
eqs_en 
0 03.05.22
DGAP-Adhoc: HAEMATO AG: Dividend of EUR 1.10http://www.haemato-ag.de/: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/13910/haematoLogo.png
DGAP-Adhoc: HAEMATO AG: Dividend of EUR 1.10
DGAP-Adhoc: HAEMATO AG: Dividend of EUR 1.10
eqs_en 
0 03.05.22
DGAP-News: Biotest AG: Biotest Supervisory Board appoints new Management Board member: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24092/375px-Biotest_logo.svg.png
DGAP-News: Biotest AG: Biotest Supervisory Board appoints new Management Board member
DGAP-News: Biotest AG: Biotest Supervisory Board appoints new Management Board member
eqs_en 
0 02.05.22
DGAP-News: Invitation to MorphoSys' First Quarter 2022 Financial Results Conference Call on May 5, 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-News: Invitation to MorphoSys' First Quarter 2022 Financial Results Conference Call on May 5, 2022
DGAP-News: Invitation to MorphoSys' First Quarter 2022 Financial Results Conference Call on May 5, 2022
eqs_en 
0 28.04.22
AEVIS VICTORIA SA - Ordinary General Meeting of Shareholders: all proposals approvedhttp://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png
AEVIS VICTORIA SA - Ordinary General Meeting of Shareholders: all proposals approved
AEVIS VICTORIA SA - Ordinary General Meeting of Shareholders: all proposals approved
eqs_en 
0 28.04.22